The FDA has awarded its latest national priority voucher to Johnson & Johnson’s Tecvayli (teclistamab-cqyv) in combination with daratumumab for the treatment of relapsed or refractory multiple myeloma ...

LINKER-MM4 trial shows linvoseltamab monotherapy achieves a 79% overall response rate in newly diagnosed MM patients, with 92 ...

Altitude has released Chris Stuckmann’s chilling horror Shelby Oaks on DVD, Blu-ray and Digital. Starring Camille Sullivan, ...

A company named around “SEO” is now tethered to a term that no longer reflects the full breadth of modern discovery work.

Consumers of all ages are looking to discs to get offline and away from algorithms, and for a younger generation, it's seen ...

You may want your offline TV to keep LAN access so you can still use some smart TV features, like phone mirroring or ...

This guide was reviewed by a Business News Daily editor to ensure it provides comprehensive and accurate information to aid your buying decision. Modern businesses run on data. Companies regularly ...

Tecvayli + Darzalex delivers superior efficacy in early relapsed MM, positioning J&J to dominate the R/R market.

Abstract: The rapid evolution of cellular technologies has resulted in a drastic increase in mobile data traffic. Particularly, in 5G cellular networks, the design of accurate time-series models ...

Resource Mining Corporation Limited ( ($AU:RMI) ) has provided an update. Resource Minerals International Ltd, listed on the ASX under the symbol ...

Patients with relapsed or refractory (R/R) multiple myeloma who received a combination of teclistamab, a bispecific monoclonal antibody, and daratumumab, a CD38-directed monoclonal antibody, were 83% ...